Radiotherapy and surgery for feline soft tissue sarcoma

Area of Science:

• Veterinary Oncology
• Radiation Oncology

Background:

• Soft tissue sarcomas are common in cats.
• Radiation therapy is a treatment modality for these tumors.

Purpose of the Study:

• To evaluate the efficacy of preoperative and postoperative radiation therapy for feline soft tissue sarcomas.
• To identify prognostic factors influencing survival in cats treated with radiation therapy.

Main Methods:

• Retrospective review of medical records for 79 cats with soft tissue sarcomas.
• Analysis of patient variables (age, weight, anemia) and radiation treatment parameters (timing, dose).

Main Results:

• Median survival was 520 days; 1-year survival was 61.6%.
• Postoperative radiation therapy (705 days median survival) showed better outcomes than preoperative (310 days).
• Anemia (packed cell volume <25%) was associated with significantly decreased survival (308 days vs. 760 days).

Conclusions:

• Radiation therapy combined with surgery offers long-term survival for cats with soft tissue sarcomas.
• Anemia is a prevalent comorbidity affecting survival in these patients.
• Timing of radiation therapy relative to surgery is a critical factor for survival.